Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000509011 | SCV000267838 | pathogenic | not provided | 2017-06-06 | criteria provided, single submitter | clinical testing | The R206W variant in the HNRNPH2 gene has been reported previously as de novo in multiple female patients with developmental delay or intellectual disability, some of whom also exhibited regression, autism, seizures, or hypotonia (Bain et al., 2016). This variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R206W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In addition, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in the same codon (R206Q) and a nearby residue (P209L) have also been reported in association with syndromic intellectual disability (Bain et al., 2016), supporting the functional importance of this region of the protein. We therefore interpret R206W as a pathogenic variant. |
Institute of Human Genetics, |
RCV000256179 | SCV000680261 | pathogenic | Mental retardation, X-linked, syndromic, Bain type | 2017-11-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000623824 | SCV000741250 | pathogenic | Inborn genetic diseases | 2016-08-18 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000256179 | SCV001141983 | pathogenic | Mental retardation, X-linked, syndromic, Bain type | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000509011 | SCV001245923 | pathogenic | not provided | 2020-06-01 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV001195298 | SCV001365617 | pathogenic | Neurodevelopmental disorder | 2019-06-05 | criteria provided, single submitter | clinical testing | The c.616C>T (p.Arg206Trp) variant in HNRNPH2 has been reported as de novo by whole exome sequencing in 19 individuals with a neurodevelopmental disorder consisting of developmental delay and variable presentation of regression, autism, tone abnormalities, seizures and/or psychiatric co-morbidities such as ADHD, anxiety, and OCD (Bain et al. 2019). It was absent from large population studies and has been reported in ClinVar (Variation ID 225760). Additionally, another missense variant at this same codon, p.Arg206Gln, has also been reported as de novo in at least two individuals with a neurodevelopmental disorder (Bain et al. 2019, Harmsen et al. 2019) and has been reported in ClinVar (Variation ID 225761). The majority of affected individuals are female. The variant occurs in a region of the protein that is critical for protein function and has been frequently altered in diseased individuals (Van Dusen et al. 2010, Bain et al. 2019). Lastly, computational prediction tools and conservation analysis support that the variant impacts protein function. In summary, this variant meets criteria to be classified as pathogenic for neurodevelopmental disorder in an X-linked dominant manner based upon case counts, de novo occurrence, a different pathogenic missense at the same position, and location at a critical residue, and predicted impact on protein. ACMG/AMP Criteria applied: PS2_VeryStrong, PM2, PM5, PM1, PP3. |
Institute for Genomic Statistics and Bioinformatics, |
RCV000256179 | SCV001437676 | pathogenic | Mental retardation, X-linked, syndromic, Bain type | criteria provided, single submitter | clinical testing | PS1, PS2, PM1, PM2, PP2 | |
Institute of Human Genetics, |
RCV000256179 | SCV001443003 | pathogenic | Mental retardation, X-linked, syndromic, Bain type | 2020-06-01 | criteria provided, single submitter | clinical testing | PS2_VeryStrong, PM2 |
Breda Genetics srl | RCV000256179 | SCV001443780 | pathogenic | Mental retardation, X-linked, syndromic, Bain type | 2020-10-22 | criteria provided, single submitter | clinical testing | The varinat c.616C>T (p.Arg206Trp) in the HNRNPH2 gene is reported as pathogenic/likely pathogenic for Bain type of X-linked syndromic mental retardation in ClinVar (Variation ID: 225760) and as pathogenic in the Global Variome shared LOVD database v.3.0. There is no information on frequency in gnomAD, 1000 Genomes or NHLI Exome Sequencing Project (ESP). This variant has been reported as pathogenic by Somashekar et al., 2019 (PMID: 31670473) and Bain et al., 2016 (PMID: 27545675). |
Institute of Medical Genetics and Applied Genomics, |
RCV000509011 | SCV001447401 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000256179 | SCV000322726 | pathogenic | Mental retardation, X-linked, syndromic, Bain type | 2016-10-07 | no assertion criteria provided | literature only | |
Genome |
RCV000256179 | SCV001443369 | pathogenic | Mental retardation, X-linked, syndromic, Bain type | 2018-04-18 | no assertion criteria provided | provider interpretation | Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2018-04-18 and interpreted as Pathogenic. The reporting laboratory might also submit to ClinVar. |